• 1. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 2. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Recent Advances in the Study of 4-(N-Ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone (CAS: 96861-52-8)

The compound 4-(N-Ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone (CAS: 96861-52-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This hydrazone derivative is known for its unique chemical properties and potential applications in drug development, particularly in the areas of photodynamic therapy and organic electronics. Recent studies have explored its synthesis, structural characterization, and biological activities, shedding light on its promising therapeutic potential.

One of the key breakthroughs in the study of this compound is its role as a photosensitizer. Researchers have demonstrated that 4-(N-Ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone exhibits strong absorption in the visible light spectrum, making it a candidate for photodynamic therapy (PDT). PDT is a non-invasive treatment modality for cancer and microbial infections, where photosensitizers generate reactive oxygen species (ROS) upon light irradiation, leading to targeted cell death. The compound's ability to efficiently produce ROS under controlled conditions has been validated in vitro, with promising results against certain cancer cell lines.

In addition to its biomedical applications, this compound has also been investigated for its use in organic electronics. Its extended π-conjugated system and electron-donating properties make it suitable for applications in organic light-emitting diodes (OLEDs) and photovoltaic devices. Recent studies have focused on optimizing its molecular structure to enhance charge transport properties and stability, which are critical for device performance. Computational modeling and experimental studies have provided insights into the relationship between its molecular structure and electronic properties, paving the way for future material design.

The synthesis of 4-(N-Ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone has also seen advancements. Recent protocols emphasize greener synthetic routes, reducing the use of hazardous reagents and improving yields. For instance, a study published in 2023 reported a one-pot synthesis method under mild conditions, which not only simplified the process but also minimized environmental impact. Such innovations are crucial for scaling up production while adhering to sustainable chemistry principles.

Despite these advancements, challenges remain in the clinical translation of this compound. Issues such as solubility, stability in biological environments, and potential toxicity need to be addressed. Ongoing research is focused on derivatization and formulation strategies to overcome these hurdles. For example, nanoparticle-based delivery systems are being explored to enhance the compound's bioavailability and target specificity.

In conclusion, 4-(N-Ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone (CAS: 96861-52-8) represents a versatile compound with significant potential in both biomedical and materials science applications. Continued research into its properties and applications is expected to yield further breakthroughs, making it a compound of interest for multidisciplinary research teams.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)